tirzepatide westshore — Dual GIP/GLP-1 Treatment Tirzepatide Weight Loss Corpus Christi
Description
Once that tissue grows, 11-beta-HSD1 activity inside the fat cells rises, converting more cortisone into active cortisol locally
The FDA is expected to rule by October 2025
In SURMOUNT-1, the 5mg group averaged 16% body weight reduction
These benefits may extend to individuals with MASH, however there are currently no retatrutide trials planned in populations with MASLD/MASH
What starting dose of tirzepatide makes sense given my current semaglutide dose
